Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when SHPH files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsShuttle Pharmaceuticals engages Bush & Associates CPA as new independent auditor
Filed November 6, 2026 · Period ending November 2, 2026 · ~1 min read
Key Changes
-
medium
Engaged Bush & Associates CPA LLC as its new independent registered public accounting firm effective November 2, 2026, following Audit Committee approval.
Item 4.01 verify on EDGAR → -
medium
Bush & Associates will audit fiscal 2026 financial statements and review quarterly financials for the first three quarters of fiscal 2027.
Item 4.01 verify on EDGAR → -
low
Company states no prior consultations with Bush & Associates on accounting principles, audit opinions, disagreements, or reportable events.
Item 4.01 verify on EDGAR →
Summary
Shuttle Pharmaceuticals Holdings, Inc. has engaged Bush & Associates CPA LLC as its new independent registered public accounting firm, effective November 2, 2026. The engagement was approved by the Audit Committee and covers the audit of the company's financial statements for the fiscal year ending December 31, 2026, as well as reviews of interim financial statements for the first three quarters of fiscal 2027. The company disclosed that it had no prior consultations with Bush & Associates regarding accounting principles, audit opinions, disagreements, or reportable events.
This is a standard disclosure accompanying a change in auditor and does not indicate any underlying financial reporting issues. The filing does not mention any disagreements with the previous auditor or other concerns.
Section-by-Section Diff
Event · Item 4.01 — Changes in Registrant's Certifying Accountant
Item 4.01 — Changes in Registrant's Certifying Accountant filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
Bush & Associates will audit the Company’s financial statements as of and for the fiscal year ending December 31, 2026, and will review the Company’s unaudited interim financial statements for the fiscal quarters ending March 31, 2027, June 30, 2027, and September 30, 2027.
The new auditor will handle the fiscal 2026 annual audit and the first three quarterly reviews of fiscal 2027. This defines the transition period for the new firm's responsibilities.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
neither the Company nor anyone acting on its behalf consulted with Bush & Associates regarding (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, and neither a written report nor oral advice was provided to the Company that Bush & Associates concluded was an important factor considered by the Company in reaching a decision as to any accounting, auditing, or financial reporting issue, or (ii) any matter that was either the subject of a disagreement (as defined in Item 304(a) (1) (iv) of Regulation S-K and the related instructions) or a reportable event (as defined in Item 304(a) (1) (v) of Regulation S-K).
The Company states it did not consult with Bush & Associates on any accounting, auditing, or financial reporting matters during the relevant periods, and there were no disagreements or reportable events. This is a standard disclosure for a new auditor engagement.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Nov 9, 2026 · How we verify